Manna, S K

Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Feb 1999 - 2095-102 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0022-1767


Aniline Compounds--antagonists & inhibitors
Biological Transport--drug effects
Cell Nucleus--drug effects
Ceramides--antagonists & inhibitors
Chloramphenicol O-Acetyltransferase--antagonists & inhibitors
Crotonates
DNA-Binding Proteins--antagonists & inhibitors
Dithiothreitol--pharmacology
Enzyme Activation--drug effects
Gene Expression Regulation--drug effects
Genes, MDR--drug effects
Genes, Reporter--drug effects
Host Cell Factor C1
Humans
Hydrogen Peroxide--antagonists & inhibitors
Hydroxybutyrates--antagonists & inhibitors
I-kappa B Proteins
Immunosuppressive Agents--antagonists & inhibitors
Isoxazoles--antagonists & inhibitors
Leflunomide
Lipopolysaccharides--antagonists & inhibitors
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)--antagonists & inhibitors
Mitogen-Activated Protein Kinase Kinases
NF-KappaB Inhibitor alpha
NF-kappa B--antagonists & inhibitors
NF-kappa B p50 Subunit
Nitriles
Octamer Transcription Factor-1
Okadaic Acid--antagonists & inhibitors
Protein Binding--drug effects
Protein Kinase Inhibitors
Protein Kinases--metabolism
Tetradecanoylphorbol Acetate--antagonists & inhibitors
Toluidines
Transcription Factor AP-1--metabolism
Transcription Factor RelA
Transcription Factors--metabolism
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha--antagonists & inhibitors